{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:04:25Z","timestamp":1789085065992,"version":"build-2803163510"},"reference-count":23,"publisher":"Centers for Disease Control MMWR Office","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm6536e1","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T12:51:08Z","timestamp":1473771068000},"page":"967-976","source":"Crossref","is-referenced-by-count":66,"title":["Vital Signs: Disparities in Antihypertensive Medication Nonadherence Among Medicare Part D Beneficiaries \u2014 United States, 2014"],"prefix":"10.15585","volume":"65","author":[{"given":"Matthew","family":"Ritchey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anping","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleetwood","family":"Loustalot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Schieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ketcham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Durthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2016,9,16]]},"reference":[{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R1","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart Disease and Stroke Statistics\u20142016 update.","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R2","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes.","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R3","article-title":"Prevalence of hypertension and controlled hypertension\u2014United States, 2007\u20132010.","volume":"62","author":"Gillespie","year":"2013","journal-title":"MMWR Suppl"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R4","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","article-title":"Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.","volume":"120","author":"Mazzaglia","year":"2009","journal-title":"Circulation"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R5","unstructured":"Gellad WFGK, McGlynn EA. A review of barriers to medication adherence: a framework for driving policy options. Santa Monica, CA: Rand Corporation; 2009. http:\/\/www.rand.org\/content\/dam\/rand\/pubs\/technical_reports\/2009\/RAND_TR765.pdf"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2165\/11595250-000000000-00000","article-title":"Medicare Part D and quality of prescription medication use in older adults.","volume":"28","author":"Lau","year":"2011","journal-title":"Drugs Aging"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R7","unstructured":"The Henry J. Kaiser Family Foundation. The Medicare Part D Prescription Drug Benefit. Menlo Park, CA: The Henry J. Kaiser Family Foundation; 2015. http:\/\/kff.org\/medicare\/fact-sheet\/the-medicare-prescription-drug-benefit-fact-sheet\/"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/MLR.0b013e3181d68978","article-title":"The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.","volume":"48","author":"Zhang","year":"2010","journal-title":"Med Care"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R9","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.5600\/MMRR.001.04.A05","article-title":"Noncompliance in the use of cardiovascular medications in the Medicare Part D population.","volume":"1","author":"Blackwell","year":"2011","journal-title":"Medicare Medicaid Res Rev"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R10","unstructured":"Nau D. Proportion of days covered (PDC) as a preferred measure of medication adherence. Springfield, VA: Pharmacy Quality Alliance (no date). http:\/\/www.pqaalliance.org\/images\/uploads\/files\/PQA%20PDC%20vs%20%20MPR.pdf"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R11","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.111.030189","article-title":"Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.","volume":"124","author":"Egan","year":"2011","journal-title":"Circulation"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R12","first-page":"127","article-title":"Progress of health plans toward meeting the million hearts clinical target for high blood pressure control\u2014United States, 2010\u20132012.","volume":"63","author":"Patel","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly.","volume":"13","author":"Maher","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R14","first-page":"814","article-title":"The implications of therapeutic complexity on adherence to cardiovascular medications.","volume":"171","author":"Choudhry","year":"2011","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/jama.2013.108769","article-title":"Improved blood pressure control associated with a large-scale hypertension program.","volume":"310","author":"Jaffe","year":"2013","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R16","first-page":"SP502","article-title":"Improving adherence to cardiovascular disease medications with information technology.","volume":"20","author":"Vollmer","year":"2014","journal-title":"Am J Manag Care"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jval.2013.03.1631","article-title":"Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension: a systematic review by the ISPOR medication adherence and persistence special interest group.","volume":"16","author":"Gwadry-Sridhar","year":"2013","journal-title":"Value Health"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R18","unstructured":"Community Preventive Services Task Force. The community guide. Cardiovascular disease prevention and control: self-measured blood pressure monitoring interventions for improved blood pressure control\u2013when used alone. Atlanta, GA: Community Preventive Services Task Force; 2015. www.thecommunityguide.org\/cvd\/SMBP-alone.html"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1001\/archinte.166.3.332","article-title":"The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.","volume":"166","author":"Shrank","year":"2006","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R20","doi-asserted-by":"publisher","first-page":"E208.","DOI":"10.5888\/pcd12.150242","article-title":"Reducing medication costs to prevent cardiovascular disease: a community guide systematic review.","volume":"12","author":"Njie","year":"2015","journal-title":"Prev Chronic Dis"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1475-6773.2009.01071.x","article-title":"Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.","volume":"45","author":"Fung","year":"2010","journal-title":"Health Serv Res"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40266-013-0074-z","article-title":"Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature.","volume":"30","author":"Sattler","year":"2013","journal-title":"Drugs Aging"},{"key":"key-10.15585\/mmwr.mm6536e1-201609151009-R23","doi-asserted-by":"publisher","first-page":"1081.e9","DOI":"10.1016\/j.amjmed.2011.05.028","article-title":"Trouble getting started: predictors of primary medication nonadherence.","volume":"124","author":"Fischer","year":"2011","journal-title":"Am J Med"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T14:10:19Z","timestamp":1473948619000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/65\/wr\/mm6536e1.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,16]]},"references-count":23,"journal-issue":{"issue":"36","published-online":{"date-parts":[[2016,9,16]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm6536e1","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,9,16]]},"published":{"date-parts":[[2016,9,16]]}}}